GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cline Scientific AB (OSTO:CLINE B) » Definitions » Piotroski F-Score

Cline Scientific AB (OSTO:CLINE B) Piotroski F-Score : 2 (As of Jun. 12, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cline Scientific AB Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cline Scientific AB has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Cline Scientific AB's Piotroski F-Score or its related term are showing as below:

OSTO:CLINE B' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 5
Current: 2

During the past 9 years, the highest Piotroski F-Score of Cline Scientific AB was 5. The lowest was 2. And the median was 4.


Cline Scientific AB Piotroski F-Score Historical Data

The historical data trend for Cline Scientific AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cline Scientific AB Piotroski F-Score Chart

Cline Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only 5.00 4.00 4.00 2.00 2.00

Cline Scientific AB Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 - 2.00 - 2.00

Competitive Comparison of Cline Scientific AB's Piotroski F-Score

For the Biotechnology subindustry, Cline Scientific AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cline Scientific AB's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cline Scientific AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Cline Scientific AB's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was kr-3.15 Mil.
Cash Flow from Operations was kr-1.73 Mil.
Revenue was kr0.00 Mil.
Gross Profit was kr4.10 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (18.817 + 22.721) / 2 = kr20.769 Mil.
Total Assets at the begining of this year (Dec22) was kr18.82 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr3.45 Mil.
Total Current Liabilities was kr1.80 Mil.
Net Income was kr-2.34 Mil.

Revenue was kr0.00 Mil.
Gross Profit was kr2.83 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (18.321 + 18.817) / 2 = kr18.569 Mil.
Total Assets at the begining of last year (Dec21) was kr18.32 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Total Current Assets was kr4.08 Mil.
Total Current Liabilities was kr0.54 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cline Scientific AB's current Net Income (TTM) was -3.15. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Cline Scientific AB's current Cash Flow from Operations (TTM) was -1.73. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-3.148/18.817
=-0.16729553

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-2.335/18.321
=-0.12744938

Cline Scientific AB's return on assets of this year was -0.16729553. Cline Scientific AB's return on assets of last year was -0.12744938. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Cline Scientific AB's current Net Income (TTM) was -3.15. Cline Scientific AB's current Cash Flow from Operations (TTM) was -1.73. ==> -1.73 > -3.15 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0/20.769
=0

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=0/18.569
=0

Cline Scientific AB's gearing of this year was 0. Cline Scientific AB's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=3.454/1.804
=1.91463415

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=4.079/0.542
=7.52583026

Cline Scientific AB's current ratio of this year was 1.91463415. Cline Scientific AB's current ratio of last year was 7.52583026. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Cline Scientific AB's number of shares in issue this year was 45.01. Cline Scientific AB's number of shares in issue last year was 23.764. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4.104/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2.825/0
=

Cline Scientific AB's gross margin of this year was . Cline Scientific AB's gross margin of last year was . ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=0/18.817
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=0/18.321
=0

Cline Scientific AB's asset turnover of this year was 0. Cline Scientific AB's asset turnover of last year was 0. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Cline Scientific AB has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Cline Scientific AB  (OSTO:CLINE B) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Cline Scientific AB Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Cline Scientific AB's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Cline Scientific AB (OSTO:CLINE B) Business Description

Traded in Other Exchanges
N/A
Address
Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.

Cline Scientific AB (OSTO:CLINE B) Headlines

No Headlines